Low Molecular Weight Hyaluronic Acid Increases the Self-Defense of Skin Epithelium by Induction of β-Defensin 2 via TLR2 and TLR4

In sites of inflammation or tissue injury, hyaluronic acid (HA), ubiquitous in the extracellular matrix, is broken down into low m.w. HA (LMW-HA) fragments that have been reported to activate immunocompetent cells. We found that LMW-HA induces activation of keratinocytes, which respond by producing β-defensin 2. This production is mediated by TLR2 and TLR4 activation and involves a c-Fos-mediated, protein kinase C-dependent signaling pathway. LMW-HA-induced activation of keratinocytes seems not to be accompanied by an inflammatory response, because no production of IL-8, TNF-α, IL-1β, or IL-6 was observed. Ex vivo and in vivo treatments of murine skin with LMW-HA showed a release of mouse β-defensin 2 in all layers of the epidermal compartment. Therefore, the breakdown of extracellular matrix components, for example after injury, stimulates keratinocytes to release β-defensin 2, which protects cutaneous tissue at a time when it is particularly vulnerable to infection. In addition, our observation might be important to open new perspectives in the development of possible topical products containing LMW-HA to improve the release of β-defensins by keratinocytes, thus ameliorating the self-defense of the skin for the protection of cutaneous tissue from infection by microorganisms.

[1]  M. Goldman,et al.  Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. , 2004, The international journal of biochemistry & cell biology.

[2]  H. van Goor,et al.  Influence of monocyte-like cells on the fibrinolytic activity of peritoneal mesothelial cells and the effect of sodium hyaluronate. , 2005, Fertility and sterility.

[3]  R. Seymour,et al.  The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration. , 2006 .

[4]  J. Shoji,et al.  Expression of β Defensins in Ocular Surface Tissue of Experimentally Developed Allergic Conjunctivitis Mouse Model , 2005, Japanese Journal of Ophthalmology.

[5]  L. Kemény,et al.  Differentiation-regulated expression of Toll-like receptors 2 and 4 in HaCaT keratinocytes , 2004, Archives of Dermatological Research.

[6]  R. Gallo,et al.  Antimicrobial peptides: an essential component of the skin defensive barrier. , 2006, Current topics in microbiology and immunology.

[7]  H. Benson,et al.  Skin peptides: biological activity and therapeutic opportunities. , 2008, Journal of pharmaceutical sciences.

[8]  L. Kemény,et al.  Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytes. , 2006, International immunopharmacology.

[9]  P. Noble,et al.  Hyaluronan in tissue injury and repair. , 2007, Annual review of cell and developmental biology.

[10]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[11]  O. Grenet,et al.  An intrinsic antibiotic mechanism in wounds and tissue-engineered skin. , 2001, The Journal of investigative dermatology.

[12]  J. Trowbridge,et al.  Innate Immunity: A Cutaneous Perspective , 2007, Clinical reviews in allergy & immunology.

[13]  J. Lee,et al.  The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's disease , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  Amanda L. Johnson,et al.  Effects of hyaluronan treatment on lipopolysaccharide-challenged fibroblast-like synovial cells , 2007, Arthritis research & therapy.

[15]  V. Falanga,et al.  Human β‐defensin‐2 expression is increased in chronic wounds , 2004 .

[16]  Shinichi Watanabe,et al.  Histamine enhances the production of human β-defensin-2 in human keratinocytes , 2007 .

[17]  S. Raghav,et al.  Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1'-1'-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L. , 2007, European journal of pharmacology.

[18]  T. Ahrens,et al.  Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4 , 2002, The Journal of experimental medicine.

[19]  R. Genco,et al.  Intracellular Signaling and Cytokine Induction upon Interactions of Porphyromonas gingivalis Fimbriae with Pattern‐Recognition Receptors , 2004, Immunological investigations.

[20]  F. Corsi,et al.  Low molecular weight hyaluronic acid prevents oxygen free radical damage to granulation tissue during wound healing. , 2002, International journal of tissue reactions.

[21]  J. Schröder,et al.  Human beta-defensin-2. , 1999, The international journal of biochemistry & cell biology.

[22]  S. Nigam,et al.  The effect of hyaluronic acid size and concentration on branching morphogenesis and tubule differentiation in developing kidney culture systems: potential applications to engineering of renal tissues. , 2007, Biomaterials.

[23]  C. Volteau,et al.  Anti-inflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis , 2008, Archives of Dermatological Research.

[24]  C. Rumio,et al.  Toll‐like receptor agonists regulate β‐defensin 2 release in hair follicle , 2007 .

[25]  G. Donnarumma,et al.  Malassezia furfur induces the expression of β-defensin-2 in human keratinocytes in a protein kinase C-dependent manner , 2004, Archives of Dermatological Research.

[26]  D. Schmitt,et al.  Use of human reconstructed epidermis to analyze the regulation of β-defensin hBD-1, hBD-2, and hBD-3 expression in response to LPS , 2003, Cell Biology and Toxicology.

[27]  K. Fukase,et al.  Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. , 2007, Molecular immunology.

[28]  J. Schröder,et al.  A peptide antibiotic from human skin , 1997, Nature.

[29]  D. Davidson,et al.  A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide , 1999, FEBS letters.

[30]  S. Krisanaprakornkit,et al.  Inducible Expression of Human β-Defensin 2 byFusobacterium nucleatum in Oral Epithelial Cells: Multiple Signaling Pathways and Role of Commensal Bacteria in Innate Immunity and the Epithelial Barrier , 2000, Infection and Immunity.

[31]  M. Kapsenberg,et al.  Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. , 2007, The Journal of investigative dermatology.

[32]  L. Schwichtenberg,et al.  Mucoid Pseudomonas aeruginosa, TNF- α , and IL-1 β , but Not IL-6, Induce Human β -Defensin-2 in Respiratory Epithelia , 2000 .

[33]  M. Kassem,et al.  Effect of hyaluronan on osteogenic differentiation of porcine bone marrow stromal cells in vitro , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[34]  G. Prestwich,et al.  Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.

[35]  H. Heng,et al.  Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation. , 1998, Gene.

[36]  M. Suico,et al.  MEF up‐regulates human β‐defensin 2 expression in epithelial cells , 2004 .

[37]  M. Horton,et al.  Hyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR21 , 2006, The Journal of Immunology.

[38]  A. Schmidtchen,et al.  Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. , 2006, The Journal of clinical investigation.

[39]  Kyong-Tai Kim,et al.  Effect of rottlerin, a PKC-δ inhibitor, on TLR-4-dependent activation of murine microglia , 2005 .

[40]  W. Cunliffe,et al.  Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. , 2001, The Journal of investigative dermatology.